Glucagon Like Peptide 1 Based Therapies: A New Horizon in Obesity Management Switching from Semaglutide to Tirzepatide: Is It a Good Idea? Hubmed Antiobesity medications in adult and pediatric obesity and metabolic dysfunctionassociated steatotic liver disease Pharmacological Reviews For an adult with type 2 diabetes mellitus who requires substantial weight loss, what are the recommended use, dosing, regulatory approval status, and contraindications of tirzepatide compared with cagrilintide, and what alternative Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet